Search results for "modality."

showing 10 items of 631 documents

Agenesis of the renal segment of inferior vena cava associated with venous stasis.

2010

Congenital anomalies of the inferior vena cava is an extremely rare vascular anomaly with controversial pathogenesis. Anomalies of the inferior vena cava (IVC) are present in 0.3% to 0.5% of otherwise healthy individual and in 0.6% to 2% of patients with other cardiovascular defects. The phenomenon of absence of the IVC has been described in a variety of ways such as absence, agenesis, anomalous, and interruption of a particular segment ([infra] hepatic, pre-renal, renal, or infrarenal) of the IVC. We describe a 42-year-old man with chronic venous insufficiency, without DVT, caused by congenital absence of renal segment of the IVC

AdultMaleSettore MED/09 - Medicina InternaCardiovascular AgentsVena Cava InferiorPhlebographySettore MED/11 - Malattie Dell'Apparato CardiovascolareCombined Modality TherapyExercise TherapyVenous InsufficiencyChronic DiseaseDiosminHumansAGENESIS OF THE RENAL SEGMENT OF INFERIOR VENA CAVA ASSOCIATED WITH VENOUS STASIS.Ultrasonography Doppler ColorTomography X-Ray ComputedStockings CompressionInternational angiology : a journal of the International Union of Angiology
researchProduct

Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients – Results of the COMPAS Study

2020

Abstract Introduction The Comparison of Methylphenidate and Psychotherapy in adult ADHD Study (COMPAS) was a prospective, randomized multicenter clinical trial, comparing methylphenidate (MPH) with placebo (PLAC) in combination with cognitive behavioral group psychotherapy (GPT) or individual clinical management (CM) over the period of 1 year. Here, we report results on treatment safety. Methods MPH and PLAC were flexibly dosed. Among 433 randomized patients, adverse events (AEs) were documented and analyzed on an “as received” basis during week 0–52. Electrocardiogram data were recorded at baseline and week 24. Results Comparing 205 patients who received ≥1 dose of MPH with 209 patients wh…

AdultMaleTachycardiamedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentMedizin610 Medicine & healthPlaceboGroup psychotherapyYoung Adult2738 Psychiatry and Mental Health03 medical and health sciences0302 clinical medicineDouble-Blind MethodInternal medicinemedicinePalpitationsHumans2736 Pharmacology (medical)Pharmacology (medical)Prospective StudiesAdverse effectCognitive Behavioral TherapyHyperhidrosisMethylphenidatebusiness.industryGeneral MedicineMiddle AgedCombined Modality Therapy3. Good health030227 psychiatryClinical trialPsychiatry and Mental healthAttention Deficit Disorder with Hyperactivity10054 Clinic for Psychiatry Psychotherapy and PsychosomaticsMethylphenidateCentral Nervous System StimulantsFemalePatient Safetymedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugPharmacopsychiatry
researchProduct

Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.

2003

Abstract Thrombotic thrombocytopenic purpura (TTP) is an uncommon hematologic thrombotic disorder characterized by fever, hemorrhagic and neurologic signs. The advent of plasma exchange has dramatically improved the prognosis of this disease, which was once inevitably fatal. However, mortality rates remain significant. Antiplatelet drugs have been widely used in combination with plasma exchange. In this pilot study we investigated the effects of an adjunctive therapy consisting of the continuous, intravenous infusion of dipyridamole, a modality of administration that has not been previously tested in this setting. Sixteen untreated TTP patients, diagnosed consecutively at our clinic, receiv…

AdultMaleTime FactorsCombination therapyThrombotic thrombocytopenic purpuraPilot ProjectsMethylprednisolonelaw.inventionRandomized controlled trialRefractorylawRecurrencemedicineHumansPlateletIn patientProspective StudiesInfusions IntravenousPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryPlatelet CountMortality rateRemission InductionHematologyDipyridamoleMiddle Agedmedicine.diseaseCombined Modality TherapyDipyridamoleTreatment OutcomeAnesthesiaFemalebusinessPlatelet Aggregation Inhibitorsmedicine.drugTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
researchProduct

Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial

2014

Purpose To compare standard-of-care grid laser photocoagulation versus intravitreal ranibizumab (IVR) versus a combination of both in the treatment of chronic (>3 months) macular oedema secondary to branch retinal vein occlusion. Methods Prospective, randomized, multicentre clinical trial. Thirty patients with a best-corrected visual acuity (BCVA) between 20/320 and 20/40 were randomized 1:1:1 to receive grid laser or three monthly injections of 0.5 mg IVR or both followed by 3 months of observation. Results Mean change from baseline BCVA at month 6 was +2 letters [laser; 0.04 logMAR, 95% confidence interval (−0.17; 0.25)], +17 letters [IVR; 0.34 (0.19; 0.5)] and +6 letters [combination; 0.…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyVisual acuitygenetic structuresVisual AcuityAngiogenesis InhibitorsAntibodies Monoclonal HumanizedMacular Edemalaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled trialRecurrencelawRanibizumabOphthalmologyRetinal Vein OcclusionHumansMedicineProspective Studies030212 general & internal medicineMacular edemaAgedAged 80 and overLaser Coagulationbusiness.industryRetinalGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyConfidence interval3. Good healthSurgeryClinical trialOphthalmologychemistryIntravitreal Injections030221 ophthalmology & optometryBranch retinal vein occlusionFemaleLasers SemiconductorRanibizumabmedicine.symptombusinessmedicine.drugActa Ophthalmologica
researchProduct

Timing flickers across sensory modalities

2009

In tasks requiring a comparison of the duration of a reference and a test visual cue, the spatial position of test cue is likely to be implicitly coded, providing a form of a congruency effect or introducing a response bias according to the environmental scale or its vectorial reference. The precise mechanism generating these perceptual shifts in subjective duration is not understood, although several studies suggest that spatial attentional factors may play a critical role. Here we use a duration comparison task within and across sensory modalities to examine if temporal performance is also modulated when people are exposed to spatial distractors involving different sensory modalities. Di…

AdultMaleVisual perceptionTime Factorsgenetic structuresAdolescentmedia_common.quotation_subjectExperimental and Cognitive PsychologyAcoustic Stimulation; Adolescent; Adult; Attention; Auditory Perception; Cues; Female; Humans; Male; Photic Stimulation; Psychophysics; Space Perception; Time Factors; Time Perception; Young Adult; Experimental and Cognitive Psychology; Sensory Systems; Artificial Intelligencebehavioral disciplines and activitiesTask (project management)Young AdultStimulus modalityArtificial IntelligencePerceptionPsychophysicsPsychophysicsHumansAttentionmedia_commonTiming flickers across sensory modalitiesResponse biasSensory SystemsOphthalmologyAcoustic StimulationDuration (music)Space PerceptionTime PerceptionAuditory stimuliAuditory PerceptionFemaleCuesPsychologypsychological phenomena and processesPhotic StimulationCognitive psychology
researchProduct

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience

2007

This study reports the first evaluation of therapeutic response in Romanian patients with Gaucher disease type I, after therapy with Cerezyme recently became available in our country.24 patients (11-50 years) received Cerezyme 20-60 U/kg every two weeks for at least 18 months. Haemoglobin, platelet count, volume of the liver and spleen, plasma chitotriosidase and the severity score were assessed every 6 months; skeletal radiography and osteodensitometry were also monitored.Eleven patients were splenectomized before start of therapy. Eight patients had anaemia (mean haemoglobin 9.4 g/dl) and 14 patients, of whom 13 were without splenectomy, had thrombocytopenia (mean 65,692/mm3). Haemoglobin…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyPediatricsTime FactorsAdolescentBone diseasemedicine.medical_treatmentDiseaseWeight GainSeverity of Illness IndexHemoglobinsGeneticsmedicineHumansIn patientChildGenetics (clinical)ChemotherapyGaucher DiseasePlatelet CountRomaniabusiness.industryLiver DiseasesRomaniannutritional and metabolic diseasesAnemiaEnzyme replacement therapyMiddle Agedmedicine.diseaseCombined Modality TherapyThrombocytopeniaRecombinant Proteinslanguage.human_languageSurgeryHexosaminidasesTreatment OutcomeSplenomegalyQuality of LifeSplenectomylanguageGlucosylceramidaseFemaleBone DiseasesbusinessFollow-Up StudiesJournal of Inherited Metabolic Disease
researchProduct

The adjunctive use of a controlled-release chlorhexidine chip following treatment with a new ultrasonic device in supportive periodontal therapy: a p…

2007

Abstract:  Objective:  The aim of this randomised, split-mouth, controlled clinical trial was to evaluate the effectiveness of a controlled-release chlorhexidine chip (CHX chip) as an adjunctive therapy to scaling and root planing (SRP) with a newly developed ultrasonic device in supportive periodontal therapy (SPT). Materials and methods:  Twenty patients with moderate-to-severe chronic periodontitis, displaying at least four sites with probing depth (PD) ≥5 mm and persistent bleeding on probing (BOP), were recruited for the study. The target sites were randomly treated with either a newly developed piezo-driven ultrasonic device VectorTM- or ultrasonic system (VUS) + CHX chip or VUS alone…

AdultMalemedicine.drug_classUltrasonic TherapyBleeding on probingDental PlaqueDentistryUltrasonic deviceScaling and root planingAntisepticPeriodontal Attachment LossmedicineHumansDentistry (miscellaneous)Periodontal Diseasesbusiness.industryChlorhexidineChlorhexidineMiddle Agedmedicine.diseaseCombined Modality TherapyControlled releaseChronic periodontitisClinical trialDelayed-Action PreparationsAnti-Infective Agents LocalDental ScalingFemalemedicine.symptomEpidemiologic Methodsbusinessmedicine.drugInternational Journal of Dental Hygiene
researchProduct

[Arterial hypertension and prediabetes].

2016

Abstract Background and objectives The aim of this study was to assess the factors related to new diabetes in hypertensive. Patients and methods This prospective follow-up study involved 2588 non-diabetic, hypertensive patients. The total follow-up was 15,053 patient-years with a median of 3.4 years (interquartile interval 1.4–6.8). Results During the follow-up, 333 (13%) patients had new diabetes, with a conversion rate of 2.21 (95% confidence interval [CI], 1.98–2.46) 100/patients/year. In a Cox proportional hazard model including baseline characteristics and modifications during the follow-up the three components of metabolic syndrome (excluding blood pressure and glucose values) HR 1.69…

AdultMalemedicine.medical_specialty030204 cardiovascular system & hematologyPrediabetic State03 medical and health sciences0302 clinical medicineInterquartile rangeRisk FactorsDiabetes mellitusInternal medicinemedicineHumans030212 general & internal medicinePrediabetesProspective StudiesFamily historyAgedProportional Hazards ModelsAged 80 and overbusiness.industryProportional hazards modelMiddle Agedmedicine.diseaseCombined Modality TherapyConfidence intervalPrimary PreventionEndocrinologyBlood pressureDiabetes Mellitus Type 2HypertensionFemaleMetabolic syndromebusinessFollow-Up StudiesMedicina clinica
researchProduct

Knee arthroscopy and exercise versus exercise only for chronic patellofemoral pain syndrome: 5-year follow-up.

2011

Objective To study the long-term outcome of arthroscopy in patients with chronic patellofemoral pain syndrome (PFPS), the authors conducted a randomised controlled trial. The authors also investigated factors predicting the outcome in patients with PFPS. Methods Fifty-six patients with PFPS were randomised into two groups: an arthroscopy group (N=28), treated with knee arthroscopy and an 8-week home exercise programme, and a control group (N=28), treated with a similar 8-week home exercise programme only. The primary outcome was the Kujala score on pain and function at 5-year. Secondary outcomes were visual analogue scales (VASs) to assess activity-related symptoms. Results According to the…

AdultMalemedicine.medical_specialty5 year follow upPhysical Therapy Sports Therapy and Rehabilitationlaw.inventionArthroscopyYoung AdultRandomized controlled triallawmedicineHumansOrthopedics and Sports MedicineIn patientYoung adultta315Knee arthroscopyIntention-to-treat analysismedicine.diagnostic_testbusiness.industryArthroscopyGeneral Medicinemedicine.diseaseCombined Modality TherapyExercise TherapyIntention to Treat AnalysisTreatment OutcomePatellofemoral Pain SyndromeChronic DiseasePhysical therapyFemalebusinessPatellofemoral pain syndromeFollow-Up StudiesBritish journal of sports medicine
researchProduct

Management of intralabyrinthine schwannomas

2006

Abstract Objectives Our protocol to manage the intralabyrinthine schwannoma (ILS). Methods Retrospective chart review of 7 consecutive patients managed for ILS. Results Five patients underwent surgical removal of the lesions and none experienced significant complications or recurrent disease. One patient refused surgical treatment and was closely followed by serial MRI scans with no signs of tumor growth. One patient is presently managed conservatively due to a good hearing. Conclusions Diagnosis of ILS is based on high resolution MRI scans and should be included in the differential diagnosis of patients investigated for cochleovestibular symptoms. Treatment modality of ILS is controversial…

AdultMalemedicine.medical_specialtyAcoustic neurinomaHearing lossLabyrinth DiseasesInner ear tumorPostoperative ComplicationsVestibular schwannomaOlder patientsVertigootorhinolaryngologic diseasesRecurrent diseaseHumansMedicineIntralabyrinthine schwannomaTumor growthIntralabyrinthine schwannomaEar NeoplasmsMeniere DiseaseRetrospective Studiesbiologybusiness.industryNeuroma AcousticGeneral MedicineMiddle Agedbiology.organism_classificationMagnetic Resonance ImagingSurgeryTreatment OutcomeOtorhinolaryngologyTreatment modalityEar InnerAudiometry Pure-ToneFemaleSurgeryDifferential diagnosismedicine.symptomAudiometry SpeechbusinessAuris Nasus Larynx
researchProduct